Allermi

Allermi: telemedicine with custom prescription nasal sprays

Allermi is an allergy care service that combines online medical consultation with the preparation of an individually formulated prescription nasal spray. The approach is based on combining several active ingredients in a single bottle, rather than relying on generic pharmacy solutions. The company presents itself as an alternative for those who do not get results from conventional over-the-counter treatments.

The service is structured around a consultation with board-certified allergists, who evaluate the patient's medical history and symptoms through a secure portal. Based on that evaluation, the medical team determines the formula and, if deemed appropriate, issues the prescription. The company states that it treats patients over 18 years of age in certain states.

The prescription nasal spray kit

The treatment is delivered as a kit that, according to the site's catalog, includes a prescription spray called Super Spray, a saline nasal mist called Salinity Spray, the online consultation with an allergist, and access to the medical care team. The site showed promotional prices for the bundle: Super Spray went from $60 to $45, the saline mist from $10 became free, the $25 consultation also became free, and access to the medical team was presented as unlimited, with a total of $95 to $45. A free five-day sample was also advertised as a limited offer.

Active ingredients and formulation approach

Each Super Spray is prescribed with up to four active ingredients, selected according to the patient's needs:

• Azelastine: a fast-acting antihistamine to calm sneezing, itching, and allergic reactions.
• Ipratropium: an anti-drip agent that addresses runny nose and post-nasal drip.
• Triamcinolone: an anti-inflammatory corticosteroid to treat and prevent inflammation.
• Oxymetazoline: a micro-dosed decongestant that clears nasal congestion without rebound, according to the product description.

The company maintains that combining several ingredients in a single spray offers superior efficacy to single-ingredient sprays, and supports this approach with 53 randomized, controlled studies and more than 18 peer-reviewed scientific publications on the use of its active ingredients.

Conditions treated and scope of service

Allermi currently treats rhinitis, that is, inflammation of the nose, also known as nasal allergies or hay fever. The company notes that it does not treat other conditions at this time. No prior allergy test is required: the treatment is aimed at both symptoms triggered by allergens such as dust, pollen, or pets and non-allergic inflammation.

The service does not accept health insurance. The company argues that it seeks to offer a single, simple price, and notes that treatments may be covered as a health expense through an HSA (health savings account) or an FSA (flexible spending account).

Formula adjustments and ongoing care

Patients can request changes to the formula if they feel the spray is not working. The allergy care team evaluates the symptoms and, if it determines that a change is the best solution, the new prescription is sent to the pharmacy within 48 hours. Access to the medical team is described as available for consultations and adjustments.

Clinical team and reviews

The site highlights a team of allergists and mentions content review by Dr. Forman. The company has accumulated more than 14,000 verified five-star reviews and states that it has treated more than 100,000 patients. According to its data, more than 90% of patients experienced greater relief than with previous solutions, and 90% achieved nearly complete or complete relief from nasal symptoms. The company also states that its patients prefer its product to Flonase, Afrin, and Astepro.

Allermi, Inc. is listed as the administrative support entity, while clinical services are provided by Allermi Medical Associates, P.C.